Dark | Light
# Edgewise Therapeutics, Inc. (EWTX)

Edgewise Therapeutics' stock hits a 52-week high driven by positive Phase [--] trial data for EDG-7500 and strong analyst ratings. Recent social posts highlight analyst reiterations of positive ratings and price targets, indicating renewed investor confidence.

### About Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for muscle disorders.  
Edgewise Therapeutics, Inc. uses the ticker $EWTX for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Edgewise Therapeutics, Inc. (EWTX) social dominance is up 75.29% from the previous week.
- Edgewise Therapeutics, Inc. Price hit a 52-Week high of $31.30 for the hour

### Price: $30
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$ewtx/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$ewtx/time-series/close.tsv)  
The stock price has hit a 52-week high, driven by positive Phase [--] trial data for EDG-7500 and strong analyst ratings. Recent social posts highlight analyst reiterations of positive ratings and price targets, further supporting this upward trend and indicating renewed investor confidence.  

24-Hour: -1.51%
7-Day: 3.13%
30-Day: 9.57%

1-Year High: $31 on 2026-02-10  
1-Year Low: $11.40 on 2025-04-12  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$ewtx/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$ewtx/time-series/alt_rank.tsv)  
Edgewise Therapeutics, Inc. (EWTX) is currently AltRank #1,207 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [-----] +183  
[--] Month: [-----] +118  
[--] Months: [-----] +418  
[--] Year: [-----] +643  
1-Year High: [-----] on 2026-02-11  
1-Year Low: [--] on 2025-04-02  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$ewtx/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$ewtx/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] [---]  
[--] Month: [--] [---]  
[--] Months: [--] [---]  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-12-24  
1-Year Low: [--] on 2025-09-19  
  
  
### Engagements: [---] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$ewtx/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$ewtx/time-series/interactions.tsv)  
Current Value: [---]  
Daily Average: [-----]  
[--] Week: [------] -47%  
[--] Month: [-------] -57%  
[--] Months: [---------] -29%  
[--] Year: [---------] -15%  
1-Year High: [-------] on 2025-04-02  
1-Year Low: [---] on 2025-10-18  

Engagements by network (24h):
TikTok: [--]
Reddit: [--]
News: [-----]
YouTube: [--]
X: [---]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$ewtx/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$ewtx/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [---] -10%  
[--] Month: [---] -34%  
[--] Months: [-----] -8.10%  
[--] Year: [-----] +11%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-09-15  

Mentions by network (24h):
TikTok: [--]
Reddit: [--]
News: [--]
YouTube: [--]
X: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$ewtx/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$ewtx/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Edgewise Therapeutics, Inc. (EWTX) in the last [--] hours which is up 5% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [--] -22%  
[--] Month: [---] -35%  
[--] Months: [---] -33%  
[--] Year: [-----] +53%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-10-18  
  
  
### Sentiment: 100%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$ewtx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$ewtx/time-series/sentiment.tsv)  
Current Value: 100%  
Daily Average: 86%  
[--] Week: 100% no change  
[--] Month: 100% +25%  
[--] Months: 100% +13%  
[--] Year: 100% +5%  
1-Year High: 100% on 2025-02-23  
1-Year Low: 33% on 2025-09-15  

Most Supportive Themes:
- Positive Sevasemten Data: (45%) Edgewise Therapeutics is presenting positive data on Sevasemten for Becker and Duchenne Muscular Dystrophies, receiving positive commentary from analysts and investors.
- Analyst Reiteration of Positive Ratings: (35%) Stifel and H.C. Wainwright have reiterated positive ratings and price targets for Edgewise Therapeutics, citing positive data and potential.
- Inclusion in Biotech Watchlists: (10%) Edgewise Therapeutics is included in biotech stock catalyst watchlists, indicating upcoming data readouts and potential catalysts.
  
Most Critical Themes:
- Stock Price Volatility: (10%) The stock price has shown volatility, with recent fluctuations and a significant drop from its 1-year high.
  
  
  
### Social Dominance: 0.00318%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$ewtx/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$ewtx/time-series/social_dominance.tsv)  
Current Value: 0.00318%  
Daily Average: 0.011%  
[--] Week: 0.00298% +0.00128%  
[--] Month: 0.0037% -0.0046%  
[--] Months: 0.0037% -0.0021%  
[--] Year: 0.0037% -0.013%  
1-Year High: 0.044% on 2025-06-28  
1-Year Low: 0.0009% on 2025-10-18  
  
  
### Market Dominance: 0.0036%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$ewtx/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$ewtx/time-series/market_dominance.tsv)  
Current Value: 0.0036%  
Daily Average: 0%  
1-Year High: 0.01% on 2025-03-31  
1-Year Low: 0.00171% on 2025-08-08  
  
  
### Market Cap: $3,177,111,704
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$ewtx/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$ewtx/time-series/market_cap.tsv)  
Current Value: $3,177,111,704  
Daily Average: $1,952,453,187  
[--] Week: $3,238,769,480 +5.10%  
[--] Month: $3,177,111,704 +9.60%  
[--] Months: $3,177,111,704 +119%  
[--] Year: $3,177,111,704 +32%  
1-Year High: $3,281,921,454 on 2026-02-10  
1-Year Low: $1,200,706,817 on 2025-04-11  

### Top Edgewise Therapeutics, Inc. News
Top news links shared on social in the last [--] hours  

*Showing a maximum of [--] news posts without a LunarCrush subscription.*

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Edgewise Therapeutics, Inc. (EWTX)

Edgewise Therapeutics' stock hits a 52-week high driven by positive Phase [--] trial data for EDG-7500 and strong analyst ratings. Recent social posts highlight analyst reiterations of positive ratings and price targets, indicating renewed investor confidence.

About Edgewise Therapeutics, Inc.

Edgewise Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for muscle disorders.
Edgewise Therapeutics, Inc. uses the ticker $EWTX for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

  • Edgewise Therapeutics, Inc. (EWTX) social dominance is up 75.29% from the previous week.
  • Edgewise Therapeutics, Inc. Price hit a 52-Week high of $31.30 for the hour

Price: $30

Price Line Chart
Price 24-Hour Time-Series Raw Data
The stock price has hit a 52-week high, driven by positive Phase [--] trial data for EDG-7500 and strong analyst ratings. Recent social posts highlight analyst reiterations of positive ratings and price targets, further supporting this upward trend and indicating renewed investor confidence.

24-Hour: -1.51% 7-Day: 3.13% 30-Day: 9.57%

1-Year High: $31 on 2026-02-10
1-Year Low: $11.40 on 2025-04-12

AltRank: [-----]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Edgewise Therapeutics, Inc. (EWTX) is currently AltRank #1,207 based on combined combined social and market metrics Daily Average: [---]
[--] Week: [-----] +183
[--] Month: [-----] +118
[--] Months: [-----] +418
[--] Year: [-----] +643
1-Year High: [-----] on 2026-02-11
1-Year Low: [--] on 2025-04-02

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-12-24
1-Year Low: [--] on 2025-09-19

Engagements: [---] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [-----]
[--] Week: [------] -47%
[--] Month: [-------] -57%
[--] Months: [---------] -29%
[--] Year: [---------] -15%
1-Year High: [-------] on 2025-04-02
1-Year Low: [---] on 2025-10-18

Engagements by network (24h): TikTok: [--] Reddit: [--] News: [-----] YouTube: [--] X: [---]

Mentions: [--] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] -10%
[--] Month: [---] -34%
[--] Months: [-----] -8.10%
[--] Year: [-----] +11%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-09-15

Mentions by network (24h): TikTok: [--] Reddit: [--] News: [--] YouTube: [--] X: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Edgewise Therapeutics, Inc. (EWTX) in the last [--] hours which is up 5% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [--] -22%
[--] Month: [---] -35%
[--] Months: [---] -33%
[--] Year: [-----] +53%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-10-18

Sentiment: 100%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 100%
Daily Average: 86%
[--] Week: 100% no change
[--] Month: 100% +25%
[--] Months: 100% +13%
[--] Year: 100% +5%
1-Year High: 100% on 2025-02-23
1-Year Low: 33% on 2025-09-15

Most Supportive Themes:

  • Positive Sevasemten Data: (45%) Edgewise Therapeutics is presenting positive data on Sevasemten for Becker and Duchenne Muscular Dystrophies, receiving positive commentary from analysts and investors.
  • Analyst Reiteration of Positive Ratings: (35%) Stifel and H.C. Wainwright have reiterated positive ratings and price targets for Edgewise Therapeutics, citing positive data and potential.
  • Inclusion in Biotech Watchlists: (10%) Edgewise Therapeutics is included in biotech stock catalyst watchlists, indicating upcoming data readouts and potential catalysts.

Most Critical Themes:

  • Stock Price Volatility: (10%) The stock price has shown volatility, with recent fluctuations and a significant drop from its 1-year high.

Social Dominance: 0.00318%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00318%
Daily Average: 0.011%
[--] Week: 0.00298% +0.00128%
[--] Month: 0.0037% -0.0046%
[--] Months: 0.0037% -0.0021%
[--] Year: 0.0037% -0.013%
1-Year High: 0.044% on 2025-06-28
1-Year Low: 0.0009% on 2025-10-18

Market Dominance: 0.0036%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.0036%
Daily Average: 0%
1-Year High: 0.01% on 2025-03-31
1-Year Low: 0.00171% on 2025-08-08

Market Cap: $3,177,111,704

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $3,177,111,704
Daily Average: $1,952,453,187
[--] Week: $3,238,769,480 +5.10%
[--] Month: $3,177,111,704 +9.60%
[--] Months: $3,177,111,704 +119%
[--] Year: $3,177,111,704 +32%
1-Year High: $3,281,921,454 on 2026-02-10
1-Year Low: $1,200,706,817 on 2025-04-11

Top Edgewise Therapeutics, Inc. News

Top news links shared on social in the last [--] hours

Showing a maximum of [--] news posts without a LunarCrush subscription.

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Edgewise Therapeutics, Inc. (EWTX)
/topic/$ewtx